Stevanato Group (NYSE:STVN) Director Donald Morel, Jr. Buys 25,000 Shares of Stock

Stevanato Group S.p.A. (NYSE:STVN) Director Donald Morel, Jr. purchased 25,000 shares of the stock in a transaction on Friday, November 6th. The shares were bought at an average price of €13.07 per share, for a total transaction of €326,750.00. Following the acquisition, the director owned 62,424 shares of the company’s stock, valued at approximately €815,881.68. The trade was a 66.80% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Stevanato Group Trading Down 0.7%

NYSE:STVN opened at €13.44 on Wednesday. Stevanato Group S.p.A. has a 12 month low of €12.05 and a 12 month high of €25.45. The firm has a market cap of $4.07 billion, a price-to-earnings ratio of 23.16, a P/E/G ratio of 1.42 and a beta of 0.80. The company has a quick ratio of 1.19, a current ratio of 1.73 and a debt-to-equity ratio of 0.22. The company’s 50 day moving average is €19.49 and its 200-day moving average is €17.95.

Stevanato Group (NYSE:STVN) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported €0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.17 by (€0.01). Stevanato Group had a return on equity of 10.51% and a net margin of 11.24%. The firm had revenue of €326.06 million for the quarter. Equities analysts anticipate that Stevanato Group S.p.A. will post 0.67 EPS for the current year.

Institutional Investors Weigh In On Stevanato Group

A number of institutional investors have recently bought and sold shares of the business. Wellington Management Group LLP bought a new stake in Stevanato Group in the 2nd quarter valued at $22,621,000. Ranger Investment Management L.P. bought a new position in shares of Stevanato Group during the 2nd quarter worth about $21,438,000. Fenimore Asset Management Inc bought a new position in shares of Stevanato Group during the 3rd quarter worth about $12,212,000. Confluence Investment Management LLC bought a new position in shares of Stevanato Group during the 2nd quarter worth about $6,062,000. Finally, Roubaix Capital LLC boosted its position in shares of Stevanato Group by 96.6% during the 1st quarter. Roubaix Capital LLC now owns 385,316 shares of the company’s stock valued at $5,298,000 after acquiring an additional 189,343 shares in the last quarter.

Wall Street Analyst Weigh In

STVN has been the subject of a number of recent analyst reports. UBS Group decreased their price target on shares of Stevanato Group from $23.00 to $16.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Deutsche Bank Aktiengesellschaft began coverage on Stevanato Group in a research note on Wednesday, October 7th. They issued a “hold” rating on the stock. Citigroup dropped their price objective on Stevanato Group from $26.00 to $20.00 and set a “buy” rating on the stock in a research note on Wednesday, November 4th. William Blair cut Stevanato Group from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 4th. Finally, Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, August 27th. Two analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Stevanato Group Company Profile

Stevanato Group is an Italian provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and diagnostic industries. Founded in 1949 by Giovanni Stevanato, the company began as a glassmaking business and has expanded into a global supplier of products and services for the life sciences sector. The company makes primary packaging for injectable medicines, including glass vials, cartridges, syringes and ampoules. Its offerings also include ready-to-use containers, as well as services such as product development, analytical testing and packaging support.